Literature DB >> 8088219

Is diabetes a public-health disorder?

F Vinicor1.   

Abstract

In the U.S., certain health conditions are readily accepted as "public-health disorders," and others continue to be primarily viewed as "clinical diseases." Reflecting on infectious conditions, it appears that disease burden, rapid change in disease incidence (suggesting preventability), and public concern about risk are three essential characteristics that define a public-health disorder. By any one of several criteria, diabetes is associated with a very high burden to individuals with the disease, as well as to society in general. Further, there is convincing and increasing evidence that primary, secondary, and tertiary prevention strategies are effective in reducing the disease burden associated with diabetes. Yet most would still consider diabetes primarily to be a clinical disease. In part, this perception is based on the fact that, in association with aging and a possible strong family history, diabetes and its complications may appear inevitable to many. Further, much of the burden associated with diabetes is insidious, coming on gradually only after a considerable number of years. Thus, the burden associated with diabetes has not dramatically increased in the past few months or years; it has been here for some time and is increasing steadily. Finally, our understanding of public concern is only now being systematically investigated. Factors that galvanize the public to demand societal or governmental action are quite complex and very different from those elements that convince the scientist/expert to request "public-health responses." Legitimate and important public-health dimensions associated with diabetes complement the critical role of clinical care. To effectively establish these public-health perspectives, public concern must be incorporated into efforts to define the burden of diabetes and our extant ability to prevent and thereby reduce this burden.

Entities:  

Mesh:

Year:  1994        PMID: 8088219

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework.

Authors:  R E Glasgow; T M Vogt; S M Boles
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

3.  Time for "drilling down".

Authors:  Frank Vinicor
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

4.  Behavioral research on diabetes at the Oregon Research Institute.

Authors:  R E Glasgow; D J Toobert; S E Hampson; W Wilson
Journal:  Ann Behav Med       Date:  1995-03

Review 5.  Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool.

Authors:  Rodolfo Valdez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  Popular misconceptions regarding the diabetes management: where should we focus our attention?

Authors:  Rajkumar Patil; Nisha Nasrin A; Shib Sekhar Datta; Abhijit V Boratne
Journal:  J Clin Diagn Res       Date:  2013-02-01

Review 7.  Pathophysiology of dyslipidaemia in the metabolic syndrome.

Authors:  G D Kolovou; K K Anagnostopoulou; D V Cokkinos
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

8.  Michigan Diabetes Outreach Networks: a public health approach to strengthening diabetes care.

Authors:  S L Krein; M L Klamerus
Journal:  J Community Health       Date:  2000-12

9.  Nerve conduction in children suffering insulin dependent diabetes mellitus.

Authors:  Funda Cenesiz; Birkan Sonel Tur; Tahsin Tezic; Yavuz Gurer
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

10.  Using the Essential Public Health Services as strategic leverage to strengthen the public health response to diabetes.

Authors:  Dawn W Satterfield; Dara Murphy; Joyce D K Essien; Gwen Hosey; Melissa Stankus; Pete Hoffman; Kaetz Beartusk; Patricia L Mitchell; Ana Alfaro-Correa
Journal:  Public Health Rep       Date:  2004 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.